Indication

As adjunctive therapy of seizures associated with tuberous sclerosis complex (TSC) for patients 2 years of age and older.

Medicine details

Medicine name:
cannabidiol (Epidyolex)
SMC ID:
SMC2402
Pharmaceutical company
GW Research Ltd
BNF chapter
Central nervous system
Submission type
Full
Publication due date:
14 February 2022
SMC meeting date:
11 January 2022
Patient group submission deadline:
01 November 2021